Christopher Cano

Christopher Cano

Founder chez C2 Strategic LLC

53 ans
Health Technology
Consumer Services
Retail Trade

Profil

Christopher Cano has founded C2 Strategic LLC in 2011, where he is currently the Managing Partner.
He has held former positions at Noven Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Agile Therapeutics, Inc., Almirall LLC, Nucryst Pharmaceuticals Corp.
(New Jersey), Liberty Medical LLC, TFF Pharmaceuticals, Inc., and Duchesnay USA, Inc. At TFF Pharmaceuticals, Inc., he was the Vice President-Business Development from 2018 to 2020.
Mr. Cano has a graduate degree from Rider University and an undergraduate degree from Villanova University.

Postes actifs de Christopher Cano

SociétésPosteDébut
C2 Strategic LLC Founder 01/01/2011
Tous les postes actifs de Christopher Cano

Anciens postes connus de Christopher Cano

SociétésPosteFin
TFF PHARMACEUTICALS, INC. Chief Operating Officer 18/12/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
AGILE THERAPEUTICS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Christopher Cano

Formation de Christopher Cano

Rider University Graduate Degree
Villanova University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Cano

Relations

14

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
AGILE THERAPEUTICS, INC.

Health Technology

TFF PHARMACEUTICALS, INC.

Health Technology

Entreprise privées7

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Health Technology

C2 Strategic LLC

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christopher Cano